This content is only available within our institutional offering.

02 Oct 2017
PANMURE: PIM designation potentially speeds route to market in the UK

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: PIM designation potentially speeds route to market in the UK
Faron Pharmaceuticals Oy (FARN:LON) | 175 -4.4 (-1.4%) | Mkt Cap: 198.7m
- Published:
02 Oct 2017 -
Author:
Julie Simmonds -
Pages:
4 -